These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6521247)

  • 1. [Effect of systemic thrombolytic therapy on necrotic focus formation in myocardial infarct patients].
    Golikov AP; Zvereva TV; Polumiskov VIu; Avilova OA
    Kardiologiia; 1984 Sep; 24(9):47-50. PubMed ID: 6521247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rate of development and the size of the necrotic focus in patients with myocardial infarct treated by intracoronary thrombolysis].
    Golikov AP; Zingerman LS; Polumiskov VIu; Berestov AA; Avilova OA
    Kardiologiia; 1986 May; 26(5):12-7. PubMed ID: 3735912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of a necrotic focus development based on data from determining the activity of the MB CPK fraction and from precardiac mapping].
    Vinogradov AV; Chekareva GA; Arutiunov GP; Serov RA; Zhuravleva IA
    Kardiologiia; 1981 Sep; 21(9):14-7. PubMed ID: 7311289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of coronary artery patency after thrombolysis by determination of the MM creatine kinase isoforms in patients with acute myocardial infarction. PRIMI Study Group.
    Schofer J; Ress-Grigolo G; Voigt KD; Mathey DG
    Am Heart J; 1992 Apr; 123(4 Pt 1):846-53. PubMed ID: 1549991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzymatic estimation of infarct size in patients undergoing thrombolytic therapy].
    Melandri G; Tartagni F; Branzi A; Berardi C; Bruscoli F; Monetti N; Magnani B
    Cardiologia; 1988 Jan; 33(1):61-7. PubMed ID: 3365710
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous thrombolytic therapy in acute infarct of the myocardium].
    Núñez P; Motta J; Arrocha A; Soto V
    Rev Med Panama; 1989 Jan; 14(1):16-25. PubMed ID: 2499016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy: an overview.
    Quaal SJ
    J Cardiovasc Nurs; 1986 Nov; 1(1):45-56. PubMed ID: 3639919
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities of electrocardiography in the evaluation of necrotization process in posterior myocardial infarction].
    Vinogradov AV; Aloev RS; Zhuravleva IA; Kharlap GV; Glazunov AS
    Kardiologiia; 1988 Nov; 28(11):58-61. PubMed ID: 3230778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction.
    Schwerdt H; Ozbek C; Fröhlig G; Schieffer H; Bette L
    Cardiovasc Res; 1990 Apr; 24(4):328-34. PubMed ID: 2189569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience using streptodecase in the prehospital stage of treatment of acute myocardial infarct].
    Mirrakhimov MM; Baltabaev TB; Tsoĭ NL
    Kardiologiia; 1987 Feb; 27(2):21-4. PubMed ID: 3573519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of thrombolytic therapy in acute myocardial infarction?
    Ganz W; Geft I
    Cardiovasc Clin; 1983; 13(1):163-72. PubMed ID: 6401226
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy update.
    Sipperly ME
    Crit Care Nurse; 1985; 5(6):30-4. PubMed ID: 3936680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intracoronary thrombolytic therapy of acute myocardial infarction].
    Astaf'ev VI; Runovich AA; Grigor'ev EG; Kustov VI; Kuril'skaia TE
    Grudn Khir; 1985; (5):58-65. PubMed ID: 3905528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serial determinations of MB CPK activity in the evaluation of the severity of acute myocardial infarct].
    Vinogradov AV; Arutiunov GP; Zhuravleva IA; Gel'fand IN; Kharlan GV
    Sov Med; 1981; (11):3-6. PubMed ID: 7336240
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of the size of the necrotic area and the rate of its formation in the acute period of myocardial infarct].
    Vinogradov AV; Arutiunov GP; Gel'fand IN; Glazunov AS; Zhuravleva IA
    Kardiologiia; 1984 Sep; 24(9):31-4. PubMed ID: 6521245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of the activity of creatine kinase in diagnosis of coronary reperfusion in patients with acute myocardial infarction after thrombolysis].
    Mysiak A; Salomon P; Halawa B
    Pol Merkur Lekarski; 1999 Aug; 7(38):58-60. PubMed ID: 10522418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thrombolytic agents: mechanism of action, efficacy, and safety.
    Kleven MR
    Heart Lung; 1988 Nov; 17(6 Pt 2):750-5. PubMed ID: 3142822
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamic characteristics of the electrocardiographic and biochemical indices in myocardial infarct patients undergoing thrombolytic therapy].
    Smirnov AA; Dorogun BN; Pomerantsev EV; Khakimov AG; Tagieva IA
    Ter Arkh; 1987; 59(10):17-21. PubMed ID: 3433210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy in acute myocardial infarct. 1. Markers for evaluating effectiveness and thrombolytic substances].
    Kothe K
    Z Gesamte Inn Med; 1990 Apr; 45(7):177-83. PubMed ID: 2198713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.